In 2019, the first gene therapy treatment for a neurogenetic disease was approved for SMA. This therapy is just the beginning, and it’s marked a tipping point in genomic analysis as it reshapes the field of neurology.
New Opioid Prescription Dosages Drop 22 Percent in Penn Medicine’s New Jersey Practices Following Changes to State Law and Health Record Alerts
Penn Medicine Information Services Named to Most Wired List for 15th Year
Awards & Accolades: September 2019
With $20 Million NIH Grant, Penn Researchers to Develop a Tool to Help Diagnose, Track Parkinson’s Disease
Penn Researchers to Develop New PET Scan Tool to Diagnose Parkinson’s
Viagra Might Help Make Stem Cell Transplants Easier
Algorithm Personalizes Which Cancer Mutations Are Best Targets for Immunotherapy
Patients Who Use Online Portals More Likely to Get Flu Shot, Penn Study Finds
Neuroscientists: Heart Disease and Diabetes Are Adaptations
Netflix’s ‘Diagnosis’ and the Ethical Perils of Medical Crowdsourcing
